İlker Ökten

517 total citations
30 papers, 353 citations indexed

About

İlker Ökten is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, İlker Ökten has authored 30 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in İlker Ökten's work include Congenital Anomalies and Fetal Surgery (3 papers), Parasitic infections in humans and animals (3 papers) and Esophageal and GI Pathology (3 papers). İlker Ökten is often cited by papers focused on Congenital Anomalies and Fetal Surgery (3 papers), Parasitic infections in humans and animals (3 papers) and Esophageal and GI Pathology (3 papers). İlker Ökten collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. İlker Ökten's co-authors include Ayten Cangır, Şevket Kavukçu, Hadı Akay, Serkan Enön, Ekber Şahin, Hakan Kutlay, Âdem Güngör, Dalokay Kılıç, Cabir Yüksel and Tuğba Akın Telli and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

İlker Ökten

25 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İlker Ökten Türkiye 10 240 125 117 79 54 30 353
Soner Gürsoy Türkiye 12 169 0.7× 106 0.8× 205 1.8× 27 0.3× 35 0.6× 54 374
Nevra Elmas Türkiye 13 299 1.2× 127 1.0× 99 0.8× 58 0.7× 118 2.2× 33 474
K. Gossios Greece 10 164 0.7× 134 1.1× 87 0.7× 32 0.4× 60 1.1× 21 310
Enver Reyhan Türkiye 11 212 0.9× 107 0.9× 54 0.5× 26 0.3× 64 1.2× 31 314
P J Valette France 10 275 1.1× 114 0.9× 69 0.6× 18 0.2× 132 2.4× 24 430
Ali Horchani Tunisia 10 182 0.8× 132 1.1× 127 1.1× 19 0.2× 11 0.2× 48 383
Levent Elbeylı Türkiye 9 166 0.7× 45 0.4× 245 2.1× 34 0.4× 28 0.5× 32 344
Lourdes del Campo Spain 8 135 0.6× 55 0.4× 82 0.7× 14 0.2× 66 1.2× 19 303
Amit Javed India 16 622 2.6× 93 0.7× 421 3.6× 45 0.6× 198 3.7× 37 684
P. Rodríguez Carnero Spain 9 152 0.6× 34 0.3× 99 0.8× 50 0.6× 47 0.9× 25 292

Countries citing papers authored by İlker Ökten

Since Specialization
Citations

This map shows the geographic impact of İlker Ökten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İlker Ökten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İlker Ökten more than expected).

Fields of papers citing papers by İlker Ökten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İlker Ökten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İlker Ökten. The network helps show where İlker Ökten may publish in the future.

Co-authorship network of co-authors of İlker Ökten

This figure shows the co-authorship network connecting the top 25 collaborators of İlker Ökten. A scholar is included among the top collaborators of İlker Ökten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İlker Ökten. İlker Ökten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ökten, İlker, et al.. (2025). Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer. Journal of Cancer Research and Clinical Oncology. 151(10). 270–270.
2.
Teker, Fatih, et al.. (2024). Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients. SHILAP Revista de lepidopterología. 25(4). 274–280.
3.
Akagündüz, Baran, Deniz Can Güven, Muhammet Özer, et al.. (2022). Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer. Journal of Geriatric Oncology. 14(2). 101367–101367.
4.
Ökten, İlker, et al.. (2022). Psychological impacts of COVID-19 pandemic in cancer patients on active treatment. Heliyon. 8(8). e10142–e10142. 8 indexed citations
5.
Şendur, Mehmet Alı Nahıt, Burcu Çakar, Sercan Aksoy, et al.. (2021). 124P Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey. Annals of Oncology. 32. S74–S74. 1 indexed citations
6.
Ökten, İlker, et al.. (2021). Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori Journal. 108(1). 19–25. 4 indexed citations
7.
Telli, Tuğba Akın, İlker Ökten, Özkan Alan, et al.. (2020). VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature. Current Problems in Cancer. 44(5). 100568–100568. 11 indexed citations
8.
Alan, Özkan, Tuğba Akın Telli, Bilge Aktaş, et al.. (2020). Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?. World Journal of Surgical Oncology. 18(1). 22 indexed citations
9.
Soydal, Çiğdem, Cabir Yüksel, Ömer Küçük, et al.. (2014). Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Esophageal Cancer Patients. Molecular Imaging and Radionuclide Therapy. 23(1). 12–15. 14 indexed citations
10.
Yüksel, Cabir, et al.. (2014). Elastofi broma Dorsi: Report of 11 Cases Analysis and Review of the Literature. Tuberkuloz ve Toraks. 62(1). 85–88.
11.
Aydın, Ömür, et al.. (2013). Oesophageal achalasia misdiagnosed as uncontrolled asthma. Tuberkuloz ve Toraks. 61(2). 147–151. 3 indexed citations
12.
Enön, Serkan, Cabir Yüksel, Ayten Cangır, et al.. (2012). Benign Localized Fibrous Tumor of the Pleura: Report of 25 New Cases. The Thoracic and Cardiovascular Surgeon. 60(7). 468–473. 14 indexed citations
13.
Yavuz, Gülsan, Emel Ünal, İlker Ökten, et al.. (2007). THE COEXISTENCE OF THYMIC CARCINOMA AND MULTIPLE GRANULOMAS IN A TURKISH CHILD. Pediatric Hematology and Oncology. 24(4). 301–307. 6 indexed citations
14.
Kılıç, Dalokay, et al.. (2006). Comparison of Mersilene Mesh–Methyl Metacrylate Sandwich and Polytetrafluoroethylene Grafts for Chest Wall Reconstruction. Journal of Investigative Surgery. 19(6). 353–360. 18 indexed citations
15.
Kavukçu, Şevket, Dalokay Kılıç, Hakan Kutlay, et al.. (2006). Parenchyma-Preserving Surgery in the Management of Pulmonary Hydatid Cysts. Journal of Investigative Surgery. 19(1). 61–68. 52 indexed citations
16.
Şahin, Ekber, Serkan Enön, Ayten Cangır, et al.. (2003). Single-stage transthoracic approach for right lung and liver hydatid disease. Journal of Thoracic and Cardiovascular Surgery. 126(3). 769–773. 36 indexed citations
17.
Cangır, Ayten, et al.. (2002). An Unusual Foreign Body in the Esophagus: Report of a Case. Surgery Today. 32(6). 523–524. 10 indexed citations
18.
Cangır, Ayten, Ekber Şahin, Serkan Enön, et al.. (2001). Surgical treatment of pulmonary hydatid cysts in children. Journal of Pediatric Surgery. 36(6). 917–920. 42 indexed citations
19.
Cangır, Ayten, Hakan Kutlay, Âdem Güngör, et al.. (2000). TORAKS TRAVMASI: 532 OLGUNUN ANALİZİ. Turkish Journal of Trauma and Emergency Surgery. 6(2). 100–105. 4 indexed citations
20.
Ökten, İlker, et al.. (1984). Akciğer Hidatik Kistleri. Turkiye Klinikleri Tip Bilimleri Dergisi. 4(3). 245–248. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026